Form D — Athos Therapeutics, Inc.
0001885079-26-000001 · filed 2026-05-15
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $20,000,000
- Total sold
- $10,282,887
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Athos Therapeutics, Inc.
- CIK
- 1885079
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1123 W. CARSON ST.
TORRANCE, CA 90502 - Phone
- 857-222-0410
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Dimitrios Iliopoulos · Executive OfficerTORRANCE, CA Find on LinkedIn ↗
-
Allan J. Pantuck · Executive OfficerTORRANCE, CA Find on LinkedIn ↗
-
Carl McKinzie · DirectorTORRANCE, CA Find on LinkedIn ↗
-
Joel Cohen · DirectorTORRANCE, CA Find on LinkedIn ↗
-
Anthony Zingale · DirectorTORRANCE, CA Find on LinkedIn ↗
-
Laurence Stein · DirectorTorrance, CA Find on LinkedIn ↗
View original on SEC EDGAR.